The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
about
Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.The Oncogene LRF Stimulates Proliferation of Mesenchymal Stem Cells and Inhibits Their Chondrogenic Differentiation.Leveraging the species barrier to advance cancer therapy.LRF inhibits p53 expression in colon cancer cells via modulating DAP5 activity.GABAB receptor regulates proliferation in the high-grade chondrosarcoma cell line OUMS-27 via apoptotic pathways.
P2860
The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The oncogene LRF is a survival ...... alignancy and drug resistance.
@en
The oncogene LRF is a survival ...... alignancy and drug resistance.
@nl
type
label
The oncogene LRF is a survival ...... alignancy and drug resistance.
@en
The oncogene LRF is a survival ...... alignancy and drug resistance.
@nl
prefLabel
The oncogene LRF is a survival ...... alignancy and drug resistance.
@en
The oncogene LRF is a survival ...... alignancy and drug resistance.
@nl
P2093
P50
P356
P1433
P1476
The oncogene LRF is a survival ...... alignancy and drug resistance.
@en
P2093
Cathy S Carlson
Jasper H N Yik
Kavita Gupta
Lalita Gupta
Paul E Di Cesare
Paula Overn
Ratna Kumari
P304
P356
10.1093/CARCIN/BGS254
P407
P577
2012-07-30T00:00:00Z